KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) FCF Payout Ratio (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 115.41%
Dec 31, 2025 273.21%
Sep 30, 2025 -40.60%
Jun 30, 2025 -52.21%
Mar 31, 2025 147.60%
Dec 31, 2024 29.91%
Sep 30, 2024 -60.84%
Jun 30, 2024 24.06%
Mar 31, 2024 60.70%
Dec 31, 2023 9.49%
Sep 30, 2023 -63.26%
Jun 30, 2023 65.49%
Mar 31, 2023 14.85%
Dec 31, 2022 15.31%
Sep 30, 2022 5,460.33%
Jun 30, 2022 -98.19%
Mar 31, 2022 13.22%
Dec 31, 2021 34.79%
Sep 30, 2021 7,672.47%
Jun 30, 2021 -99.08%
Mar 31, 2021 -8.69%
Dec 31, 2020 -30.85%
Sep 30, 2020 105.33%
Jun 30, 2020 -13.67%
Mar 31, 2020 -21.67%
Dec 31, 2019 22.04%
Sep 30, 2019 -20.03%
Jun 30, 2019 -37.13%
Mar 31, 2019 182.04%
Dec 31, 2018 -67.69%
Sep 30, 2018 -18.70%
Jun 30, 2018 9.13%
Mar 31, 2018 -5.78%
Dec 31, 2017 67.87%
Sep 30, 2017 -8.36%
Jun 30, 2017 -58.12%
Mar 31, 2017 93.99%
Dec 31, 2016 -1.00%
Sep 30, 2016 -83.23%
Jun 30, 2016 361.57%
Mar 31, 2016 -232.19%
Dec 31, 2015 -51.51%
Sep 30, 2015 132.31%
Jun 30, 2015 -617.93%
Mar 31, 2015 -18.99%
Dec 31, 2014 109.27%
Sep 30, 2014 18.65%
Jun 30, 2014 -47.86%
Mar 31, 2014 154.25%
Dec 31, 2013 -23.22%
Sep 30, 2013 52.52%
Jun 30, 2013 138.12%
Mar 31, 2013 -225.85%
Dec 31, 2012 560.99%
Sep 30, 2012 -77.20%
Jun 30, 2012 -74.32%
Mar 31, 2012 461.61%
Dec 31, 2011 11.75%
Sep 30, 2011 -36.98%
Jun 30, 2011 -60.16%
Mar 31, 2011 272.62%
Dec 31, 2010 -12.13%
Sep 30, 2010 -25.46%
Jun 30, 2010 -65.33%
Mar 31, 2010 201.63%
Dec 31, 2009 13.59%